We are live on ! Find out more
SGI

Summit Global Investments Portfolio holdings

AUM $1.83B
1-Year Est. Return 22.56%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+22.56%
3 Year Est. Return
+60.44%
5 Year Est. Return
+82.72%
10 Year Est. Return
AUM
$1.36B
AUM Growth
-$201M
Cap. Flow
-$140M
Cap. Flow %
-10.3%
Top 10 Hldgs %
19.52%
Holding
678
New
143
Increased
156
Reduced
122
Closed
215

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$14.9M
2
KHC icon
Kraft Heinz
KHC
+$14.4M
3
PFE icon
Pfizer
PFE
+$12.9M
4
GILD icon
Gilead Sciences
GILD
+$12.6M
5
ABBV icon
AbbVie
ABBV
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 15.27%
2 Consumer Staples 13.37%
3 Technology 13.34%
4 Financials 10.6%
5 Industrials 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGG icon
1
iShares Core US Aggregate Bond ETF
AGG
$137B
$58.1M 4.28%
542,507
-73,984
-12% -$8.14M
AAPL icon
2
Apple
AAPL
$4.46T
$28.2M 2.08%
161,473
-54,905
-25% -$9.23M
MSFT icon
3
Microsoft
MSFT
$3.62T
$26.9M 1.98%
87,116
-42,452
-33% -$12.8M
WMT icon
4
Walmart Inc
WMT
$881B
$24.2M 1.79%
487,893
-160,839
-25% -$7.55M
VRTX icon
5
Vertex Pharmaceuticals
VRTX
$119B
$23.6M 1.74%
90,562
-4,482
-5% -$1.06M
PFE icon
6
Pfizer
PFE
$143B
$21.8M 1.61%
421,532
+248,130
+143% +$12.9M
MRK icon
7
Merck
MRK
$316B
$21.7M 1.6%
264,861
+113,497
+75% +$8.95M
HSY icon
8
Hershey
HSY
$35.7B
$20.3M 1.5%
93,720
+23,841
+34% +$4.84M
PGR icon
9
Progressive
PGR
$122B
$20.1M 1.48%
176,194
-19,842
-10% -$2.15M
BMY icon
10
Bristol-Myers Squibb
BMY
$134B
$19.9M 1.47%
273,035
-65,419
-19% -$4.39M
XOM icon
11
ExxonMobil
XOM
$643B
$19.9M 1.47%
241,282
+111,125
+85% +$8.64M
ABBV icon
12
AbbVie
ABBV
$433B
$19.9M 1.47%
122,805
+79,584
+184% +$11.6M
ISTB icon
13
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.12B
$19M 1.4%
392,931
-61,427
-14% -$3.03M
TGT icon
14
Target
TGT
$67.8B
$18.3M 1.35%
86,084
-38,612
-31% -$8.35M
ADBE icon
15
Adobe
ADBE
$99.9B
$17.1M 1.26%
37,552
-19,342
-34% -$9.31M
USMV icon
16
iShares MSCI USA Min Vol Factor ETF
USMV
$23.7B
$16.8M 1.24%
216,808
+75,298
+53% +$5.7M
INTU icon
17
Intuit
INTU
$87.1B
$16.6M 1.23%
34,613
-4,235
-11% -$2.17M
K
18
DELISTED
Kellanova
K
$15.6M 1.15%
258,381
+247,070
+2,184% +$14.9M
KHC icon
19
Kraft Heinz
KHC
$31.3B
$15.2M 1.12%
+385,268
New +$14.4M
FDX icon
20
FedEx
FDX
$73.2B
$15M 1.11%
65,008
+377
+0.6% +$88.6K
INCY icon
21
Incyte
INCY
$24B
$14.6M 1.08%
183,871
+148,270
+416% +$10.8M
CVX icon
22
Chevron
CVX
$385B
$13.9M 1.03%
85,611
-557
-0.6% -$79.9K
SO icon
23
Southern Company
SO
$107B
$13.4M 0.99%
185,011
+109,210
+144% +$7.4M
VZ icon
24
Verizon
VZ
$198B
$13.4M 0.99%
263,219
+35,121
+15% +$1.86M
ACGL icon
25
Arch Capital
ACGL
$34.5B
$12.5M 0.92%
257,758
+129,175
+100% +$6.01M

Similar funds

Summit Global Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Summit Global Investments held 678 positions worth $1.36B, down 13% from $1.56B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Summit Global Investments withdrew a net $140M in Q1 2022, closing 215 positions and reducing 122 holdings. Its most notable exit was Idexx Laboratories, an estimated $24.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Summit Global Investments opened a new position in Kraft Heinz worth $15.2M.

  • Summit Global Investments's largest Q1 2022 buy was Kraft Heinz: 385,268 shares worth $15.2M.
  • Summit Global Investments added most to Kellanova in Q1 2022, an estimated $14.9M increase.
  • Summit Global Investments's biggest Q1 2022 reduction was Amazon, cutting an estimated $26.4M.
  • Summit Global Investments fully exited Idexx Laboratories in Q1 2022, selling an estimated $24.9M.
  • Summit Global Investments's ten largest holdings make up 20% of its $1.36B portfolio in Q1 2022.
  • Summit Global Investments opened 143 new positions and closed 215 in Q1 2022.
  • Summit Global Investments's portfolio value fell 13% quarter-over-quarter to $1.36B.

Based on Summit Global Investments's 13F filing for Q1 2022, filed 29 Apr 2022.